1Fhist Y. Subcomm ittee for scleroderma criteria of the american rheumatism association diagno sis and therapeutic criteria committee. Pretim inary criteria for classtification of system ic sclero sis[J]. A rth ritis Rheum, 1980, 23(5) : 581.
2American Thoracic Society (ATS). Idiopathic Pulmonary Fibrosis: Diagnosis and Treadment [J ]. Am J Respir Crit Care Med, 2000, 61(12): 646.
1[1]Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis[J].Arthritis Rheum,1980,23∶581-586.
2[2]Medsger TA.Systemic sclerosis and localized scleroderma.In: Schumacher HR,eds. Primer on the rheumatic diseases[M].Athlanta: Arthritis Fundation,1988.111-128.
3[3]Chappell LT,Janson M.EDTA chelation therapy in the treatment of vascular disease[J].J Cardiovasc Nurs,1996,10(3)∶78-86.
9Mittag M, Haustein UF. Progressive systemic scleroderma-prognosis determining involvement of internal organ systems [ J ]. Hautarzt, 1998,49(7) :545-551.
10Hata N, Kunimi T, Matsuda H, et al. Cardiac disorders associated with progressive systemic sclerosis [ J ]. J Cardiol, 1998,32 ( 6 ) : 397-402.
